Novozymes A/S is a Denmark-based biotechnology company engaged in the production and sale of industrial enzymes, microorganisms and biopharmaceutical ingredients. The Company operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. It develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.
Industry, Sector and Symbol:
- Sector: Basic Materials
- Industry: N/A
- Sub-Industry: N/A
- Symbol: OTCMKTS:NVZMY
- CUSIP: N/A
- Web: www.novozymes.com
- Market Cap: $13.29 billion
- Outstanding Shares: 251,256,000
- 50 Day Moving Avg: $42.76
- 200 Day Moving Avg: $38.24
- 52 Week Range: $31.57 - $49.55
Sales & Book Value:
- Trailing P/E Ratio: 29.89
- Foreward P/E Ratio: 25.28
- P/E Growth: 23.69
- Annual Revenue: $2.09 billion
- Price / Sales: 5.38
- Book Value: $5.40 per share
- Price / Book: 8.29
- Annual Dividend: $0.33
- Dividend Yield: 1.3%
- EBIDTA: $735.1 million
- Net Margins: 21.57%
- Return on Equity: 27.48%
- Return on Assets: 16.97%
- Current Ratio: 1.79%
- Quick Ratio: 1.10%
- Average Volume: 21,297 shs.
- Beta: 0.96
Frequently Asked Questions for Novozymes A/S - (OTCMKTS:NVZMY)
What is Novozymes A/S -'s stock symbol?
Novozymes A/S - trades on the OTCMKTS under the ticker symbol "NVZMY."
How were Novozymes A/S -'s earnings last quarter?
Novozymes A/S - (OTCMKTS:NVZMY) posted its quarterly earnings results on Thursday, August, 6th. The company reported $0.33 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by $0.02. Novozymes A/S - had a net margin of 21.57% and a return on equity of 27.48%. View Novozymes A/S -'s Earnings History.
Where is Novozymes A/S -'s stock going? Where will Novozymes A/S -'s stock price be in 2017?
4 analysts have issued twelve-month price objectives for Novozymes A/S -'s shares. Their predictions range from $47.50 to $47.50. On average, they expect Novozymes A/S -'s share price to reach $47.50 in the next year. View Analyst Ratings for Novozymes A/S -.
Who are some of Novozymes A/S -'s key competitors?
Some companies that are related to Novozymes A/S - include Svenska Cellulosa SCA AB (SVCBY), GMK Noril'skiy nikel' PAO (NILSY), ArcelorMittal SA (MT), International Paper Co (IP), Akzo Nobel (AKZOY), POSCO (PKX), Barrick Gold Corp (ABX), Nucor (NUE), Newmont Mining Corp (NEM), Anglo American plc (NGLOY), Freeport-McMoRan (FCX), Alumina Limited (AWCMY), UPM-Kymmene (UPMKY), Fresnillo Plc (FNLPF), Potash Co. of Saskatchewan (POT), WestRock Co (WRK), Franco Nevada Corp (FNV) and Koninklijke DSM (RDSMY).
How do I buy Novozymes A/S - stock?
Shares of Novozymes A/S - can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Novozymes A/S - stock cost?
One share of Novozymes A/S - stock can currently be purchased for approximately $44.75.
Earnings History for Novozymes A/S - (OTCMKTS:NVZMY)Earnings History by Quarter for Novozymes A/S - (OTCMKTS:NVZMY)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
Earnings Estimates for Novozymes A/S - (OTCMKTS:NVZMY)
Current Year EPS Consensus Estimate: $1.61 EPS
Next Year EPS Consensus Estimate: $1.77 EPS
Dividend History for Novozymes A/S - (OTCMKTS:NVZMY)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Novozymes A/S - (OTCMKTS:NVZMY)
No insider trades for this company have been tracked by MarketBeat.com
Headline Trends for Novozymes A/S - (OTCMKTS:NVZMY)
Latest Headlines for Novozymes A/S - (OTCMKTS:NVZMY)
Novozymes A/S - (NVZMY) Chart for Saturday, May, 27, 2017